These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30578516)

  • 41. Treatment of facial angiofibromas of tuberous sclerosis by shave excision and dermabrasion in a dark-skinned patient.
    Fischer K; Blain B; Zhang F; Richards L; Lineaweaver WC
    Ann Plast Surg; 2001 Mar; 46(3):332-5. PubMed ID: 11293529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anesthesia concerns for children with tuberous sclerosis.
    Septer S; Thompson ES; Willemsen-Dunlap A
    AANA J; 2006 Jun; 74(3):219-25. PubMed ID: 16786916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
    Sener S; Sasmaz S
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberous sclerosis complex (TSC) and Klippel-Trenaunay-Weber (KTW) syndromes association of two complete phakomatoses in a single individual.
    Assefa G; Alemie B
    Ethiop Med J; 2010 Oct; 48(4):315-20. PubMed ID: 21280434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal division and gene expression in cultured cells from a patient with tuberous sclerosis.
    Onodera K; Ishibashi Y; Sasaki M; Kimura G
    J Dermatol; 1989 Aug; 16(4):263-9. PubMed ID: 2600265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.
    Schwartz RA; Fernández G; Kotulska K; Jóźwiak S
    J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tuberous sclerosis: a case report.
    Babu KL; Rai K; Hegde AM
    J Clin Pediatr Dent; 2004; 28(4):347-9. PubMed ID: 15366626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tuberous sclerosis in childhood].
    Pires CF; Anunciação GM; De Sousa WL; Santos BM; Anunciação FA; Pires AF; Pires LF
    Dermatol Online J; 2008 Sep; 14(9):14. PubMed ID: 19061596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.
    Tu J; Foster RS; Bint LJ; Halbert AR
    Australas J Dermatol; 2014 Feb; 55(1):63-9. PubMed ID: 24359523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.
    Cinar SL; Kartal D; Bayram AK; Canpolat M; Borlu M; Ferahbas A; Per H
    Indian J Dermatol Venereol Leprol; 2017; 83(1):27-32. PubMed ID: 27643542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
    Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
    Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis?
    Anliker MD; Dummer R; Burg G
    Dermatology; 1997; 195(2):176-8. PubMed ID: 9310731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tuberous sclerosis syndrome: clinical and EEG studies in 100 children.
    Pampiglione G; Moynahan EJ
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):666-73. PubMed ID: 186565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel.
    Krakowski AC; Nguyen TA
    Pediatrics; 2015 Sep; 136(3):e709-13. PubMed ID: 26304829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuberous sclerosis: computed tomography diagnosis.
    Rafal RB; Ndzengue A; Jaffe EA
    J Emerg Med; 2013 Feb; 44(2):e259-61. PubMed ID: 22626853
    [No Abstract]   [Full Text] [Related]  

  • 56. Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment.
    Curatolo P; Bombardieri R; Verdecchia M; Seri S
    J Child Neurol; 2005 Apr; 20(4):318-25. PubMed ID: 15921233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tuberous sclerosis, early onset of seizures, and mental subnormality: study of discordant homozygous twins.
    Gomez MR; Kuntz NL; Westmoreland BF
    Neurology; 1982 Jun; 32(6):604-11. PubMed ID: 7201091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of tranilast on angiofibromas of tuberous sclerosis.
    Wang L; Gao L; Abe T; Mizoguchi M
    Pediatr Int; 1999 Dec; 41(6):701-3. PubMed ID: 10618896
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuropsychiatric aspects of tuberous sclerosis.
    Curatolo P; Cusmai R; Cortesi F; Chiron C; Jambaque I; Dulac O
    Ann N Y Acad Sci; 1991; 615():8-16. PubMed ID: 2039170
    [No Abstract]   [Full Text] [Related]  

  • 60. CATATONIC SCHIZOPHRENIA ASSOCIATED WITH TUBEROUS SCLEROSIS.
    ZLOTLOW M; KLEINER S
    Psychiatr Q; 1965 Jul; 39():466-75. PubMed ID: 14328152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.